These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 36557793)

  • 1. Recent Trends and Developments in Multifunctional Nanoparticles for Cancer Theranostics.
    Rabaan AA; Bukhamsin R; AlSaihati H; Alshamrani SA; AlSihati J; Al-Afghani HM; Alsubki RA; Abuzaid AA; Al-Abdulhadi S; Aldawood Y; Alsaleh AA; Alhashem YN; Almatouq JA; Emran TB; Al-Ahmed SH; Nainu F; Mohapatra RK
    Molecules; 2022 Dec; 27(24):. PubMed ID: 36557793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent nanotheranostic approaches in cancer research.
    Gupta D; Roy P; Sharma R; Kasana R; Rathore P; Gupta TK
    Clin Exp Med; 2024 Jan; 24(1):8. PubMed ID: 38240834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2D Nanomaterials for Cancer Theranostic Applications.
    Cheng L; Wang X; Gong F; Liu T; Liu Z
    Adv Mater; 2020 Apr; 32(13):e1902333. PubMed ID: 31353752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances in Theranostic Applications of Nanomaterials in Cancer.
    Ahmed F; Khan MA; Haider N; Ahmad MZ; Ahmad J
    Curr Pharm Des; 2022; 28(2):133-150. PubMed ID: 34530703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status of Cancer Nanotheranostics: Emerging strategies for cancer management.
    Chavda VP; Khadela A; Shah Y; Postwala H; Balar P; Vora L
    Nanotheranostics; 2023; 7(4):368-379. PubMed ID: 37151802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer Nanotheranostics: A Nanomedicinal Approach for Cancer Therapy and Diagnosis.
    Kundu P; Singh D; Singh A; Sahoo SK
    Anticancer Agents Med Chem; 2020; 20(11):1288-1299. PubMed ID: 31429694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted Nanotheranostics for Future Personalized Medicine: Recent Progress in Cancer Therapy.
    Jo SD; Ku SH; Won YY; Kim SH; Kwon IC
    Theranostics; 2016; 6(9):1362-77. PubMed ID: 27375785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theranostic Applications of Nanomaterials in Alzheimer's Disease: A Multifunctional Approach.
    Tripathi P; Shukla P; Bieberich E
    Curr Pharm Des; 2022; 28(2):116-132. PubMed ID: 34809540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging strategies in developing multifunctional nanomaterials for cancer nanotheranostics.
    Ang MJY; Chan SY; Goh YY; Luo Z; Lau JW; Liu X
    Adv Drug Deliv Rev; 2021 Nov; 178():113907. PubMed ID: 34371084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanomedicine And Nanotheranostics: Special Focus on Imaging of Anticancer Drugs Induced Cardiac Toxicity.
    Setia A; Challa RR; Vallamkonda B; Satti P; Mehata AK; Priya V; Kumar S; Muthu MS
    Nanotheranostics; 2024; 8(4):473-496. PubMed ID: 38961885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining gene therapy with other therapeutic strategies and imaging agents for cancer theranostics.
    Azevedo A; Farinha D; Geraldes C; Faneca H
    Int J Pharm; 2021 Sep; 606():120905. PubMed ID: 34293466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical Modification of Chitosan for Developing Cancer Nanotheranostics.
    Li X; Wang Y; Feng C; Chen H; Gao Y
    Biomacromolecules; 2022 Jun; 23(6):2197-2218. PubMed ID: 35522524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinspired approaches for cancer nanotheranostics.
    Evangelopoulos M; Tasciotti E
    Nanomedicine (Lond); 2017 Jan; 12(1):5-7. PubMed ID: 27876435
    [No Abstract]   [Full Text] [Related]  

  • 14. All-in-One Nanomedicine: Multifunctional Single-Component Nanoparticles for Cancer Theranostics.
    Cai Y; Chen X; Si J; Mou X; Dong X
    Small; 2021 Dec; 17(52):e2103072. PubMed ID: 34561968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Green Synthesized Nanomaterials as Theranostic Platforms for Cancer Treatment: Principles, Challenges and the Road Ahead.
    Rajasekharreddy P; Huang C; Busi S; Rajkumari J; Tai MH; Liu G
    Curr Med Chem; 2019; 26(8):1311-1327. PubMed ID: 28294042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted nanotheranostics for personalized cancer therapy.
    Diou O; Tsapis N; Fattal E
    Expert Opin Drug Deliv; 2012 Dec; 9(12):1475-87. PubMed ID: 23092183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supramolecular cancer nanotheranostics.
    Zhou J; Rao L; Yu G; Cook TR; Chen X; Huang F
    Chem Soc Rev; 2021 Feb; 50(4):2839-2891. PubMed ID: 33524093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomimetic theranostic nanoparticles for effective anticancer therapy and MRI imaging.
    Bigaj-Józefowska MJ; Coy E; Załęski K; Zalewski T; Grabowska M; Jaskot K; Perrigue P; Mrówczyński R; Grześkowiak BF
    J Photochem Photobiol B; 2023 Dec; 249():112813. PubMed ID: 37977004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanotheranostics for Diagnosis and Treatment of Breast Cancer.
    Patel P; Kumar K; Jain VK; Popli H; Yadav AK; Jain K
    Curr Pharm Des; 2023; 29(10):732-747. PubMed ID: 36999427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Advancement of Nanotheranostics in Cancer Applications.
    Parveen S; Abira R; Paikray S; Sahoo L; Tripathy NS; Dilnawaz F
    Curr Drug Deliv; 2024 May; ():. PubMed ID: 38812425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.